Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-02 09:04 am Purchase | 2025-04-15 | 13G | Cara Therapeutics, Inc. CARA | Ronald A. DePinho | 780,990 8.300% | 780,990 (New Position) | Filing History |
| 2025-05-02 4:24 pm Purchase | 2025-04-15 | 13G | Cara Therapeutics, Inc. CARA | Samuel D. Tweardy | 946,974 10.100% | 946,974 (New Position) | Filing History |
| 2025-05-02 4:21 pm Purchase | 2025-04-15 | 13G | Cara Therapeutics, Inc. CARA | David J. Tweardy | 652,398 7.000% | 652,398 (New Position) | Filing History |
| 2025-04-22 2:26 pm Purchase | 2025-04-15 | 13G | Cara Therapeutics, Inc. CARA | Solas Tvardi Sidecar LLC | 761,287 8.100% | 761,287 (New Position) | Filing History |
| 2025-04-16 4:15 pm Purchase | 2025-04-15 | 13D | Tvardi Therapeutics, Inc. TVRD | Vifor (International) Ltd. | 205,465 2.200% | 205,465 (New Position) | Filing History |
| 2024-12-18 5:10 pm Unchanged | 2024-12-17 | 13D | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 205,466 13.500% | 0 (Unchanged) | Filing History |
| 2024-10-30 4:21 pm Unchanged | 2024-10-23 | 13D | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 205,466 13.500% | 0 (Unchanged) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 20,686 1.400% | -78,043 (-79.05%) | Filing History |
| 2024-02-13 6:50 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III, LP | 0 0.000% | -74,890 (Position Closed) | Filing History |
| 2024-02-13 5:01 pm Sale | 2023-12-29 | 13G | Cara Therapeutics, Inc. CARA | The Vanguard Group | 73,085 4.830% | -13,074 (-15.17%) | Filing History |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 98,729 6.500% | -4,103 (-3.99%) | Filing History |
| 2023-07-25 4:40 pm Unchanged | 2023-07-25 | 13G | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 205,466 13.700% | 0 (Unchanged) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 102,832 6.900% | -111,904 (-52.11%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Cara Therapeutics, Inc. CARA | The Vanguard Group | 86,159 5.770% | 1,916 (+2.27%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 214,737 14.400% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 214,737 14.400% | 14,761 (+7.38%) | Filing History |
| 2022-11-18 4:16 pm Purchase | 2022-11-09 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III, LP | 74,890 5.000% | 74,890 (New Position) | Filing History |
| 2022-02-14 6:16 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO. LLC. | 0 0.000% | -89,244 (Position Closed) | Filing History |
| 2022-02-14 11:35 am Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | RHO Ventures VI LP | 22 0.000% | -77,730 (-99.97%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | The Vanguard Group | 84,243 5.670% | 84,243 (New Position) | Filing History |